Navigation Links
Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
Date:1/12/2009

CAMBRIDGE, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced that it has initiated a proof-of-concept study of IDX184, a liver-targeted nucleotide prodrug candidate for the treatment of HCV under an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA). The study is evaluating IDX184 in treatment-naive hepatitis C genotype-1 infected patients.

"We are very pleased with the progress that we have made in our hepatitis C discovery program in 2008, having successfully advanced IDX184 from IND to a proof-of-concept study, while simultaneously advancing two additional HCV discovery programs into IND-enabling preclinical studies," said Jean-Pierre Sommadossi, Ph.D., chief executive officer of Idenix. "As we work to finalize a partnership for our lead HIV drug candidate, our goal in 2009 is to become the first biopharmaceutical company with innovative drugs from three major classes of direct-acting hepatitis C antivirals in clinical development."

The proof-of-concept trial in HCV-infected patients is being conducted at multiple centers around the world. The trial design is a phase I/II, double-blind, placebo-controlled, dose-escalation study to evaluate the safety and antiviral activity of IDX184 in treatment-naive adult patients infected with chronic hepatitis C. The study will evaluate four doses of IDX184, ranging from 25 to 100 mg once-per-day, administered for three days. Each cohort of the study will evaluate ten patients randomized eight to IDX184 and two to placebo.

About IDX184

IDX184 is a once-daily, oral nucleotide prodrug candidate based on Idenix's proprietary li
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
2. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
3. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
4. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
5. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
6. Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia
7. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
8. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
9. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015  Avellino Labs ( http://www.avellinolab.com/us/ ), the global ... that the World Economic Forum (WEF) has recognized it ... Avellino Labs is one of 49 companies selected ... and impact global health. "We are honored ... World Economic Forum for Avellino,s breakthrough DNA test technology," ...
(Date:8/5/2015)...  Prescription drug prices fall significantly over time ... of the U.S. health care system. Innovator companies ... to patients, and over time those medicines become ... of all medicines prescribed to U.S. patients are ... percent less than the original brand medicine. ...
(Date:8/5/2015)... 2015 A new report ... Systems - Market Opportunity and Forecast, 2014-2020", the ... of $399.7 million by 2020, registering a CAGR ... capsules segment held around 95% share in the ... market throughout the forecast period.      ...
Breaking Medicine Technology:Avellino Labs Named 2015 Technology Pioneer by World Economic Forum 2Avellino Labs Named 2015 Technology Pioneer by World Economic Forum 3Avellino Labs Named 2015 Technology Pioneer by World Economic Forum 4Then and Now: How Prescription Drug Prices Fall Significantly Over Time 2Then and Now: How Prescription Drug Prices Fall Significantly Over Time 3Capsule Endoscopy Systems Market is Expected to Reach $399.7 Million by 2020 2Capsule Endoscopy Systems Market is Expected to Reach $399.7 Million by 2020 3
... May 21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Squibb Company (NYSE: ... which showed that treatment with Baraclude (entecavir),demonstrated ... 48 weeks,-- a result that was also ... These data from an open-label, randomized viral ...
... -- Data presented,today at a major medical meeting ... for five days is as,effective as standard therapy ... treatment of complicated urinary tract infections,(cUTI) and acute ... markets LEVAQUIN in the,U.S., presented the data during ...
Cached Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4
(Date:8/5/2015)... ... August 05, 2015 , ... While heading back ... requires school physicals and vaccinations to protect children from many preventable diseases. MD ... convenient, hassle free, and affordable for parents to prepare their children for a ...
(Date:8/5/2015)... ... August 05, 2015 , ... Hotze Health & Wellness ... to announce that it has added Electronic Beam Computed Tomography (EBCT) imaging to ... will be used primarily for conducting coronary artery scans and virtual colonoscopies. , ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... Stand Foundation to help fight childhood cancer. All proceeds go directly to supporting ... , Alex’s Lemonade Stand Foundation began in the front yard of childhood ...
(Date:8/5/2015)... ... ... makers of the nation’s leading line of recovery drinks, has answered consumers’ calls once more, ... is smooth, rich and ready to travel, in three flavors. It tastes awesome because it’s ... milk and sugar to taste great like other traditional ready to drink coffees. , ...
(Date:8/5/2015)... ... August 05, 2015 , ... Florida Hospital Carrollwood ... for medical and emergency response training. The high-tech human patient simulators provide risk-free ... blink, bleed, cry, suffer a heart attack or show signs of a drug ...
Breaking Medicine News(10 mins):Health News:Pack Up Children’s Back-to-School Essentials at MD Now Urgent Care 2Health News:Pack Up Children’s Back-to-School Essentials at MD Now Urgent Care 3Health News:Pack Up Children’s Back-to-School Essentials at MD Now Urgent Care 4Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 2Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 3Health News:AskDoctorParker.com Supports Alex’s Lemonade Stand Foundation 2Health News:Kill Cliff® Releases Epic New Product Line – Coffeehouse Quality Cold Brew Coffee in a Can 2Health News:Florida Hospital Carrollwood is Partnering with CAE Healthcare to Help Save Lives with an Emergency Response Training Simulation Lab 2Health News:Florida Hospital Carrollwood is Partnering with CAE Healthcare to Help Save Lives with an Emergency Response Training Simulation Lab 3
... from terminal cancer. The zoo officials are seeking to make ... as possible. // A large node or lymphoma has been ... developing rapidly. ,Even though surgeries have been ... to live for more than a few weeks as the ...
... more than 80 people in Asia and many countries fear that ... various researches are been done to develop a new dug to ... institute have found that Sambucol (an extract from elderberries) is very ... ,This is found to be 99% effective but they also ...
... samples and their personal information about their lifestyle, diet, ... two biggest medical research projects, the British Project called ... still in its infancy and the Biobank would be ... blood samples and your personal lifestyle information and they ...
... new study appearing in the January 18 issue of The ... triggered off when adult neurons try to undergo division. This ... behind the development of the disease. ,"If ... stop neurons from dying prematurely. This could be a fresh ...
... the Indian State of Bihar has been given the task ... Chief Minister is reported to have given him //the task ... ,Sources close to Nitish Kumar said his prime concern ... state, but eliminating mosquitoes was also a priority. The problem ...
... demand for medical staff, it has been proposed to ... role, currently played by nurses, podiatrist surgeons and other ... them into vacant postitions. // ,It has led ... The proposal would be taken up for consideration during ...
Cached Medicine News:Health News:Dividing Nerve Cells Could Trigger Alzheimer's Disease 2Health News:Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals 2
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: